Table 2. Survival analysis.
Univariate | Multivariate | |||
Parameter | HR | p-value | HR | p-value |
TN | 2.83 | 4.9*10−7 | 1.72 | 0.06 |
Grade 3 vs. 1 or 2 | 1.57 | 0.03 | 0.87 | 0.55 |
Stage III vs. IIA or IIB | 2.42 | 1.5*10−5 | 1.58 | 0.05 |
Age >50 | 1.03 | 0.89 | 1.02 | 0.91 |
Lymph node positivevs. negative | 3.16 | 4.2*10−5 | 2.17 | 0.02 |
PC1a>median PC1a | 0.86 | 0.69 | 0.87 | 0.73 |
PC2a>median PC2a | 0.69 | 0.08 | 0.91 | 0.66 |
PC3a>median PC3a | 1.81 | 0.003 | 1.75 | 0.01 |
PC4a>median PC4a | 0.364 | 7.3*10−6 | 0.52 | 0.02 |
PC5a>median PC5a | 1.22 | 0.33 | 1.21 | 0.36 |
PC6a>median PC6a | 1.61 | 0.02 | 1.30 | 0.21 |
A Cox proportional hazard model demonstrated that the third and fourth principal components had significant effects on survival of patients, even when accounting for clinical variables.